These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6627096)

  • 1. Metabolism of NG-monomethyl-L-arginine.
    Paik WK; Abou-Gharbia M; Swern D; Lotlikar P; Kim S
    Can J Biochem Cell Biol; 1983 Aug; 61(8):850-5. PubMed ID: 6627096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine metabolism in experimental glomerulonephritis: interaction between nitric oxide synthase and arginase.
    Cook HT; Jansen A; Lewis S; Largen P; O'Donnell M; Reaveley D; Cattell V
    Am J Physiol; 1994 Oct; 267(4 Pt 2):F646-53. PubMed ID: 7524362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nitric oxide synthase substrate analog inhibitors on rat liver arginase.
    Robertson CA; Green BG; Niedzwiecki L; Harrison RK; Grant SK
    Biochem Biophys Res Commun; 1993 Dec; 197(2):523-8. PubMed ID: 7505570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine.
    Hecker M; Mitchell JA; Harris HJ; Katsura M; Thiemermann C; Vane JR
    Biochem Biophys Res Commun; 1990 Mar; 167(3):1037-43. PubMed ID: 2322257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity.
    Boutard V; Havouis R; Fouqueray B; Philippe C; Moulinoux JP; Baud L
    J Immunol; 1995 Aug; 155(4):2077-84. PubMed ID: 7636258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-arginine binding to liver arginase requires proton transfer to gateway residue His141 and coordination of the guanidinium group to the dimanganese(II,II) center.
    Khangulov SV; Sossong TM; Ash DE; Dismukes GC
    Biochemistry; 1998 Jun; 37(23):8539-50. PubMed ID: 9622506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N omega-hydroxyl-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase.
    Boucher JL; Custot J; Vadon S; Delaforge M; Lepoivre M; Tenu JP; Yapo A; Mansuy D
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1614-21. PubMed ID: 7945311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide synthase activity is inducible in rat, but not rabbit alveolar macrophages, with a concomitant reduction in arginase activity.
    Hey C; Wessler I; Racké K
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Jun; 351(6):651-9. PubMed ID: 7545789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelium-dependent relaxation and L-arginine metabolism in genetic hypertension.
    Lee L; Webb RC
    Hypertension; 1992 May; 19(5):435-41. PubMed ID: 1568761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N omega-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation.
    Ishii K; Chang B; Kerwin JF; Huang ZJ; Murad F
    Eur J Pharmacol; 1990 Feb; 176(2):219-23. PubMed ID: 2155799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells.
    Hibbs JB; Vavrin Z; Taintor RR
    J Immunol; 1987 Jan; 138(2):550-65. PubMed ID: 2432129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase.
    Hey C; Boucher JL; Vadon-Le Goff S; Ketterer G; Wessler I; Racké K
    Br J Pharmacol; 1997 Jun; 121(3):395-400. PubMed ID: 9179379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginase is a major pathway of L-arginine metabolism in nephritic glomeruli.
    Jansen A; Lewis S; Cattell V; Cook HT
    Kidney Int; 1992 Nov; 42(5):1107-12. PubMed ID: 1280702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes.
    Tratsiakovich Y; Kiss A; Gonon AT; Yang J; Sjöquist PO; Pernow J
    Diab Vasc Dis Res; 2017 May; 14(3):236-245. PubMed ID: 28183205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis.
    MacAllister RJ; Fickling SA; Whitley GS; Vallance P
    Br J Pharmacol; 1994 May; 112(1):43-8. PubMed ID: 7518309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-arginine and arginine analogues: effects on isolated blood vessels and cultured endothelial cells.
    Schmidt HH; Baeblich SE; Zernikow BC; Klein MM; Böhme E
    Br J Pharmacol; 1990 Sep; 101(1):145-51. PubMed ID: 2282457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible role of endogenous inhibitor for nitric oxide synthesis in the bovine ciliary muscle.
    Azuma H; Masuda H; Sato J; Niwa K; Tokoro T
    Exp Eye Res; 1997 May; 64(5):823-30. PubMed ID: 9245913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic and metabolic inferences from the binding of substrate analogues and products to arginase.
    Cox JD; Cama E; Colleluori DM; Pethe S; Boucher JL; Mansuy D; Ash DE; Christianson DW
    Biochemistry; 2001 Mar; 40(9):2689-701. PubMed ID: 11258880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of striatal arginine and citrulline metabolism by nitric oxide synthase inhibitors.
    Ohta K; Shimazu K; Komatsumoto S; Araki N; Shibata M; Fukuuchi Y
    Neuroreport; 1994 Mar; 5(7):766-8. PubMed ID: 7517194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic GMP stimulation by vasopressin in LLC-PK1 kidney epithelial cells is L-arginine-dependent.
    Schröder H; Schrör K
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):475-7. PubMed ID: 2555724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.